These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4086728)

  • 21. Antibody-mediated suppression of tumor growth. III. Molecular assay of murine IgG1 alloantibody required to cause tumor suppression in vivo.
    Johnson RJ; Pasternack GR; Drysdale BE; Shin HS
    J Immunol; 1977 Feb; 118(2):498-504. PubMed ID: 839068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of host immunity with 5-fluorouracil-initiated cure of plasmacytoma LPC-1 in BALB/c mice.
    Teller MN; Faanes RB
    Cancer Res; 1980 Aug; 40(8 Pt 1):2790-5. PubMed ID: 6966969
    [No Abstract]   [Full Text] [Related]  

  • 23. Growth characteristics of MOPC-315 plasmacytoma and response to anticancer agents.
    Valeriote F; Lynch R; Berger NA; White E; Coulter D
    J Natl Cancer Inst; 1981 Jun; 66(6):1083-8. PubMed ID: 7017213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytotoxic T lymphocytes to murine plasmacytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL.
    Kaneko Y; Natsuume-Sakai S; Migita S
    J Immunol; 1978 Aug; 121(2):427-37. PubMed ID: 79604
    [No Abstract]   [Full Text] [Related]  

  • 25. Detection of a possible precursor of immunoglobulin light chain in MOPC 41 A plasmacytoma cells.
    Schmeckpeper BJ; Adams JM; Harris AW
    FEBS Lett; 1975 Apr; 53(1):95-8. PubMed ID: 1170095
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of intraperitoneal pristane on established immunity to the adj-PC-5 plasmacytoma.
    Potter M; Walters JL
    J Natl Cancer Inst; 1973 Sep; 51(3):875-81. PubMed ID: 4743559
    [No Abstract]   [Full Text] [Related]  

  • 27. Myeloproliferation in long-term plasmacytoma-regressor mice.
    Sagi-Assif O; Douer D; Shaked N; Russell SW; Witz IP
    Int J Cancer; 1994 Jan; 56(2):208-13. PubMed ID: 8314303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA sequences involved in the rearrangement and expression of the murine c-myc gene.
    Dunnick W; Baumgartner J; Fradkin L; Schultz C
    Curr Top Microbiol Immunol; 1984; 113():154-60. PubMed ID: 6478863
    [No Abstract]   [Full Text] [Related]  

  • 29. Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation.
    Rohrer JW; Vasa K; Lynch RG
    J Immunol; 1977 Sep; 119(3):861-6. PubMed ID: 330758
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccination with tumor cells engineered to secrete interleukin 2-immunoglobulin G fusion protein induces tumor rejection.
    Bulfone-Paus S; von Bernuth H; Rückert R; Wachtlin J; Ungureanu D; Notter M; Krause H; Pohl T; Paus R; Kunzendorf U
    Cancer Res; 1998 Jul; 58(13):2707-10. PubMed ID: 9661877
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of interleukin-6 in the pathogenesis of murine plasmacytoma and human multiple myeloma.
    Pattengale PK
    Am J Pathol; 1997 Sep; 151(3):647-9. PubMed ID: 9284811
    [No Abstract]   [Full Text] [Related]  

  • 32. Mutations in immunoglobulin-producing mouse myeloma cells.
    Baumal R; Birshtein BK; Coffino P; Scharff MD
    Science; 1973 Oct; 182(4108):164-6. PubMed ID: 4354174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of low-dose melphalan treatment against a nonimmunogenic primary induced mouse plasmacytoma.
    Ophir R; Pick AI; Ben-Efraim S
    Anticancer Res; 1987; 7(1):91-6. PubMed ID: 3566188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and intracellular transport of immunoglobulin in secretory and nonsecretory cells.
    Sherr CJ; Schenkein I; Uhr JW
    Ann N Y Acad Sci; 1971 Dec; 190():250-67. PubMed ID: 5290018
    [No Abstract]   [Full Text] [Related]  

  • 35. Plasmacytomas and murine immunoglobulins.
    Smith-Gill SJ; Finkelman FD; Potter M
    Methods Enzymol; 1985; 116():121-45. PubMed ID: 4088082
    [No Abstract]   [Full Text] [Related]  

  • 36. The metabolism of different immunoglobulin classes in irradiated mice. IV. Fate of circulating IgA of tumour or transfusion origin.
    Bazin H; Levi G; Heremans JF
    Immunology; 1971 Apr; 20(4):563-70. PubMed ID: 5553069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction by cyclophosphamide administration of two distinct anti-tumor effector cells at tumor site and spleen of mice transplanted with MOPC-104E plasmacytoma.
    Nio Y; Ohgaki K; Tobe T
    J Clin Lab Immunol; 1989 May; 29(1):37-43. PubMed ID: 2534133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A plasmacytoma-specific factor binds the c-myc promoter region.
    Kakkis E; Calame K
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7031-5. PubMed ID: 3313385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MOPC 104E plasmacytoma functional heterogeneity and maturational potential in culture.
    Miura T; Hiramoto RN; Ghanta VK
    Cancer Res; 1983 Mar; 43(3):953-8. PubMed ID: 6825114
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of protective antitumor immune response against a murine plasmacytoma not curable by alkylating-drug treatment.
    Ophir R; Jackman A; Relyveld EH; Ben-Efraim S
    Anticancer Res; 1990; 10(1):231-5. PubMed ID: 2334133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.